According to uniQure's latest financial reports the company's total liabilities are $0.62 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $0.62 B | 172.55% |
2022-12-31 | $0.22 B | 7.29% |
2021-12-31 | $0.21 B | 121.17% |
2020-12-31 | $96.49 M | -23.16% |
2019-12-31 | $0.12 B | 33.16% |
2018-12-31 | $94.3 M | -21.6% |
2017-12-31 | $0.12 B | -5.01% |
2016-12-31 | $0.12 B | -6.01% |
2015-12-31 | $0.13 B | 110.24% |
2014-12-31 | $64.08 M | 38.93% |
2013-12-31 | $46.12 M | 479.87% |
2012-12-31 | $7.95 M | -26.91% |
2011-12-31 | $10.88 M | -9.52% |
2010-12-31 | $12.02 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Amgen AMGN | $90.92 B | 14,470.39% | ๐บ๐ธ USA |
Sanofi SNY | $57.61 B | 9,132.57% | ๐ซ๐ท France |
Sangamo Therapeutics
SGMO | $82.43 M | -86.79% | ๐บ๐ธ USA |
bluebird bio
BLUE | $0.39 B | -37.33% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $1.89 B | 202.88% | ๐บ๐ธ USA |
Avidity Biosciences RNA | $0.12 B | -79.52% | ๐บ๐ธ USA |